Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 401–500 of 574
Petersen, S. M., Ibsen, D. B., & Andersen, A. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01875-x · Cited by 3
Jeong, I., Choi, K. M., Han, K. A., Kim, K., Kim, I. J., Han, S. J., Lee, W., & Yoo, S. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15838 · Cited by 4
Understanding Diabetes Remission
Velayutham, K., Panneerselvam, G., & Ramanathan, B. (2025) · Apollo Medicine · doi:10.1177/09760016251323727 · Cited by 4
The Pathobiology of Diabetes Mellitus
Jenkins, A. J., O'Neal, D. N., Nolan, C. J., & Januszewski, A. S. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-45307-1_1 · Cited by 3
Strengthening a Study of Diabetes Progression After Statin Use
Ganatra, R. B., Bhatnagar, A., & Herzig, S. J. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.8353 · Cited by 3
Kim, M., Kim, H., Kim, K. Y., Kim, S. Y., Jung, J., Hahm, J. R., Jung, J., & Baek, J. H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0373 · Cited by 4
You, C., & Cui, Y. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/29/20240801 · Cited by 6
Nigam, A., Sun, J., Subhash, V., Aiello, L. P., Silva, P. S., Huang, Y., & Luo, G. (2024) · Studies in computational intelligence · doi:10.1007/978-3-031-63592-2_9 · Cited by 5
Bình, T. D., Kusunoki, R., Nguyen, T. Q. C., Nakagami, A., Kanaori, K., Nguyen, Y. D. H., Pham, T. L. A., Nguyen, C. C., Le, V. V., & Kamei, K. (2020) · Records of Natural Products · doi:10.25135/rnp.194.20.06.1697 · Cited by 3
Overcoming psychological insulin resistance: A practical guide for healthcare professionals
Snoek, F. J., Fisher, L., Polonsky, W. H., Stuckey, H. L., Hessler, D., Tang, T. S., Hermanns, N., Mundet, X., Silva, M. L., Sturt, J. A., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.03.001 · Cited by 3
Nazu, N. A., Wikström, K., Lamidi, M., Lindström, J., Tirkkonen, H., Rautiainen, P., & Laatikainen, T. K. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01889-3 · Cited by 3
Artificial Intelligence for Iris-Based Diagnosis in Healthcare
Agarwal, R., Samant, P., Bansal, A., & Agarwal, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-2074-7_106 · Cited by 3
Jang, S., Shin, S., Jeong, Y., & Lim, D. (2023) · Organoid · doi:10.51335/organoid.2023.3.e16 · Cited by 4
Lage, M. J., Eby, E. L., Brunt, K. V., Brusko, C., & Curtis, B. H. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s76398 · Cited by 3
TRAUTMANN, M. E., & Vora, J. P. (2018) · Diabetic Medicine · doi:10.1111/dme.13610 · Cited by 3
Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes
Finsen, S. H., Hansen, M. R., Hoffmann‐Petersen, J., Højgaard, H. F., & Mortensen, S. P. (2021) · Physiological Reports · doi:10.14814/phy2.14971 · Cited by 3
Zhao, Y., Xie, L., Zhang, H., Zhou, S., Liu, Y., Chen, J., Wang, L., Wang, L., Lang, Z., Wang, Y., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.12.009 · Cited by 3
Sharma, M., Kohli, S., & Pal, A. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i3.15310 · Cited by 3
Rai, P., Zhao, X., & Sambamoorthi, U. (2018) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2018.1546789 · Cited by 3
Gastric bypass prevents diabetes in genetically modified mice and chemically induced diabetic mice
Zhu, C., Xu, R., Li, Y., Andrade, M. S., & Yin, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258942 · Cited by 3
Insulin Pumps and Artificial Pancreas
Taleb, N., Gingras, V., & RABASA-LHORET, R. P. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65407-7 · Cited by 3
Rodeles, L. M., Vicco, M. H., Siano, Á., Fuchs, L. A., Peverengo, L. M., Puch, S. I. S., Cymeryng, C. B., Marcipar, I. S., & Arias, P. (2021) · Pathogens · doi:10.3390/pathogens10030378 · Cited by 2
Tan, M. S., Kim, K., Olsen, C. J., & Brixner, D. I. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100127 · Cited by 3
Dicembrini, I., Poggi, C. D., Vescovo, G. G. D., Marinelli, C., Scoccimarro, D., Vitale, V., Silverii, G. A., Drigani, L., Pancani, F., Norgiolini, R., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70511 · Cited by 2
Kibirige, D., Sekitoleko, I., Lumu, W., & Nyirenda, M. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02169-4 · Cited by 2
Wainwright, P., Oluwatowoju, I., Ryan, A., Abu, E. O., & Byrne, C. D. (2015) · Diabetic Medicine · doi:10.1111/dme.12853 · Cited by 2
Bonora, E., Bryzinski, B. S., Hirshberg, B., & Cook, W. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.11.004 · Cited by 4
Sheth, J. J. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.05.00122 · Cited by 2
Hassanein, M., Dahi, W. A., Radhi, H. T., AIMahfouz, A., Kaabi, J. A., Alshammari, A. M., Al-Futaisi, A., Almalki, M., & Malik, R. A. (2022) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000521437 · Cited by 2
Zeliger, H. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91890-9.00027-1 · Cited by 3
Formulation and Characterization of Gastroretentive Drug Delivery System of Teneligliptin
Aparna., A., Reichal, C. R., & Shobana., M. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00814 · Cited by 2
Presta, M., Zoratto, F., Mulder, D., Ottomana, A. M., Pisa, E., Vásquez, A. A., Slattery, D. A., Glennon, J. C., & Macrì, S. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107102 · Cited by 2
Chang, X., Cai, L., Wang, J., Dong, H., Han, J. R., & Wang, C. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202400287 · Cited by 2
Prevalence and characteristics of prediabetes in workers in industry
Reynolds, R. (2019) · Journal of Advanced Nursing · doi:10.1111/jan.14276 · Cited by 2
Loprinzi, P. D. (2014) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-201403000-00003 · Cited by 2
Practical aspects of usage of insulin in India: Descriptive review and key recommendations
Mukherjee, J. J., Rajput, R., Majumdar, S., Saboo, B., & Chatterjee, S. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.04.018 · Cited by 2
Ruyatkina, L. A., Ruyatkin, D. S., & Iskhakova, I. S. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-7-33-44 · Cited by 2
Causal Interpretability and Uncertainty Estimation in Mixture Density Networks
Swamy, G., Das, A., & Niranjan, S. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-44192-9_20 · Cited by 2
Docherty, P. D., Chase, J. G., Morenga, L. T., & Fisk, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814536511 · Cited by 2
Lixandru, D., Băcanu, E. V., Vîrgolici, B., Emil, M., Gagniuc, P. A., Ionescu-Tirgoviste, C., & Serafinceanu, C. (2015) · Cited by 3
Online Support System for Diabetes Management
Owonaro Peter, A., N., O., & O., J. (2016) · International Journal of Computer Applications · doi:10.5120/ijca2016911454 · Cited by 2
Hirahara, N., Kaneda, T., Muraoka, H., Ito, K., Hara, Y., & Tokunaga, S. (2020) · International Journal of Oral-Medical Sciences · doi:10.5466/ijoms.19.179 · Cited by 2
Aldahash, R., Kamal, A., Amir, A., Shabaan, A., Ewias, D., Jnaid, H., Almalki, M., Najjar, N., Deegy, N., Khedr, S., et al. (2022) · Cureus · doi:10.7759/cureus.23612 · Cited by 2
Choi, Y., Song, J. E., Kim, E., Kim, C. H., Lee, J. E., & Song, H. (2023) · Yonsei Medical Journal · doi:10.3349/ymj.2022.0554 · Cited by 2
Arnolds, S., & Sawicki, P. T. (2015) · Diabetes Care · doi:10.2337/dc14-2418 · Cited by 2
Meyers, E. E., Lira, V. A., Rahmouni, K., & Stauss, H. M. (2016) · doi:10.17077/etd.fimve4iz · Cited by 2
Espe, A. (2019) · NDSU Repository (North Dakota State University) · Cited by 4
Durr, A. J. (2022) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11325 · Cited by 2
Stringent glycemic control is still the key to evade diabetic retinopathy.
Alam, S. M., Ahmed, S., Bano, S., & Perveen, S. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.05.4077 · Cited by 1
Post-transcriptional gene regulation in metabolic syndrome
Pathak, R., & Kumar, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91305-8.00003-x · Cited by 1
Alluhidan, M., Alabdulkarim, H. A., Alrumaih, A. M., Alturaiki, A., Alshahrani, A. M., AL-Qahtani, S. S., Alhossan, A., & Al-Jedai, A. H. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2277056 · Cited by 2
Zainudin, A. M., Rasool, A. H. G., Nor, M. Z. M., Hassan, N. B., Muhamad, R., & Mohamed, W. M. I. W. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.2.9 · Cited by 1
Preventive and Therapeutic Efficacy of Roselle Beverage Residue in Late-Stage Type 2 Diabetic Rats
Regalado-Rentería, E., Serna-Tenorio, J. E., García-Gutiérrez, D. G., Reynoso‐Camacho, R., García, O. P., Anaya‐Loyola, M. A., & Pérez‐Ramírez, I. F. (2024) · Beverages · doi:10.3390/beverages10020040 · Cited by 2
Type 2 Diabetes Mellitus in Ayurveda w.s.r to Medovaha Srotas
Saranya, K., Ratheesh, P., Subash, S., Vinitha, C., & Michael, N. (2024) · AYUSHDHARA · doi:10.47070/ayushdhara.v11i3.1568 · Cited by 1
Al‐Dwairi, A., Al-Shboul, O. A., Al-U'datt, D. G. F., Saadeh, R., Alqudah, M., Khassawneh, A., Alfaqih, M. A., Albtoush, A., Hweidi, A. I., & Alnemer, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313627 · Cited by 4
Yu, N., Xu, W., Guo, X., Xu, M., Zhang, W., Yan, C., Pang, S., Shu, X., Zhang, W., Peng, W., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16427 · Cited by 1
Li, W., Chen, Z., Lin, H., Hu, S., Chen, K., Guo, Y. F., Wu, S., Li, H., Chen, Y., & Li, Z. (2025) · Journal of Biophotonics · doi:10.1002/jbio.202500096 · Cited by 1
Age, glucose tolerance, and cognitive performance in female vervet monkeys
Frye, B. M., Davis, T. G., Chen, H., Register, T. C., Craft, S., Baxter, M. G., & Shively, C. A. (2025) · GeroScience · doi:10.1007/s11357-025-01920-2 · Cited by 2
Gillett, A. C., Handley, D., Bala, R., Young, K., Tyrrell, J., & Lewis, C. M. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.04.003 · Cited by 1
CHENG, A. Y. Y., Anil, G., Canani, L. H. S., VINTHER, S. M., Wang, N., & Mathieu, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70358 · Cited by 1
Mattiello, A., Barbaglio, G., Magnone, M., Scarfı̀, S., Vernazza, S., Mirata, S., Markus, J., Letašiová, S., Riva, D., & Premoli, R. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1740097 · Cited by 1
Waterman, H. L., Smith, M. S., Farmer, B., Yankey, K. C., Bosma, K. J., O'Brien, R. M., Claxton, D. P., Howard, T., Kraft, G., Cherrington, A. D., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1832065 · Cited by 1
Shin, M. H., Jeong, J. W., Ha, S. E., Singh, R., Lee, M. Y., Ro, S., & Yu, T. Y. (2026) · Pharmaceuticals · doi:10.3390/ph19050791 · Cited by 1
Harbuwono, D. S., Wardhani, Y., Hadinata, E., Rohmah, S. N., Hendrawan, A. F., Ambari, A. M., Puspitasari, M., Kuswadi, D. P., Nugroho, P., Ginanjar, E., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02233-w · Cited by 1
Impacts of premenopausal type 2 diabetes on female reproductive aging: a scoping review
Brand, J., Craig, T. V., & Templeman, N. M. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.109105 · Cited by 1
Pharmacometrics Approaches and its Applications in Diabetes: An Overview
Aziz, S., Harun, S. N., Sulaiman, S. A. S., & Ghadzi, S. M. S. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_399_21 · Cited by 1
Yabe, D., Matsuhisa, M., Takahashi, Y., Morimoto, Y., & Terauchi, Y. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01531-8 · Cited by 1
Zhang, K., Zhao, A., Wang, Z., Ye, K., Xu, Z., Gong, X., & Zhu, G. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01449-1 · Cited by 1
Diabetes mellitus: An overview
Sonia, T. A., & Sharma, C. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30272-5.00007-x · Cited by 1
Strongman, H., D’Oca, K., Langerman, H., & Das, R. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12458 · Cited by 1
Saxagliptin Responder Analysis: A Pooled Analysis of 5 Clinical Trials
Sjöstrand, M., & Leibowitz, G. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000657 · Cited by 1
Garg, R. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0135 · Cited by 1
Benjamens, S., Leemkuil, M., & Pol, R. A. (2019) · Clinical Transplantation · doi:10.1111/ctr.13726 · Cited by 1
Mafuta-Munganga, D., Sakou, R. F. E.-L., Longo‐Mbenza, B., Mokondjimobé, E., & Nimi, B. M. (2021) · Science Journal of Clinical Medicine · doi:10.11648/j.sjcm.20211001.12 · Cited by 1
Quan, H., Fang, T., Lin, L., Lü, L., Ou, Q., Zhang, H., Chen, K., & Zhou, Z. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01102-1 · Cited by 2
Combination Tratment of Oral Agents and Insulin in Type 2 Diabetes: A Narrative Review
(2016) · International Journal of Diabetes & Metabolic Disorders · doi:10.33140/ijdmd/00004 · Cited by 2
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00010-3 · Cited by 2
Harris, S. B., & Seidu, S. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.10.008 · Cited by 1
Diabetes and Its Associated Factors among Oil and Gas Company Workers in Port Harcourt
Chinoso, O. S., Ordinioha, B., Penuel, A., Fente, A. E., & Clement, T. (2023) · Saudi Journal of Medicine · doi:10.36348/sjm.2023.v08i11.004 · Cited by 1
Cluster analysis based on fasting and postprandial plasma glucose and insulin concentrations
Altuve, M., & Severeyn, É. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01322-8 · Cited by 1
Changing the Conversation: a Critical Ethnography of Diabetes Care in People with Mental Illnesses
Knyahnytska, Y. (2017) · TSpace (University of Toronto) · Cited by 1
Schrijnders, D. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.103517830 · Cited by 1
Freeman, J. S. (2013) · Osteopathic Family Physician · doi:10.1016/j.osfp.2012.11.001
The Effect of Aerobic Exercise Training on Hepatic Glycogen Metabolism in Type 1 Diabetic Rats
Murray, M. (2015) · Scholarship@Western (Western University) · Cited by 1
Islet amyloid polypeptide (IAPP) in Type 2 diabetes and Alzheimer disease
Oskarsson, M. E. (2015) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Estudo experimental da exposição ao PCB126 sobre a indução de Diabetes mellitus tipo II
Shimada, A. L. B. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2016.tde-25022016-113849
Dipeptidyl-Peptidase IV inhibitors and glycemic control in type 2 Diabetes Mellitus
Sapkota, L. B., & Thapa, S. (2016) · Journal of College of Medical Sciences-Nepal · doi:10.3126/jcmsn.v12i1.14684
Uso de estatinas e o risco de Diabetes Mellitus tipo 2: Revisão Baseada na Evidência
Silva, S., & Monteiro, N. (2016) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc11(38)1178
Type 2 diabetes mellitus (T2DM) onset and "remission".
Tangelloju, S. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2515 · Cited by 1
Dipeptidyl-peptidase IV inhibitors and glycemic control in type 2 diabetes mellitus
Sapkota, L. B., & Thapa, S. (2017) · Journal of Chitwan Medical College · doi:10.3126/jcmc.v6i1.16656
Marathe, C. S. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
A Carbohydrate Counting Intervention for Hispanics with Type 2 Diabetes
Cattaneo, F. (2017) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/thesis-cattaneo-flavia-2017
Regulation of pancreatic beta-cell function by the renin-angiotensin system in type 2 diabetes
Shoemaker, R. (2015) · UKnowledge (University of Kentucky)
Endocrine Disorders: Integrative Treatments of Hypothyroidism, Diabetes, and Adrenal Dysfunction
Yang, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190466268.003.0014
Role of Lysine Acetylation in the Control of Cardiac Energy Metabolism
Alrub, A. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3g15tk4x
Lin, Q. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3016 · Cited by 1
Role of oral hypoglycemic drugs on inflammatory condition associated with type 2 diabetes mellitus
Mohiuddin, S. S. (2018) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2018.05.00141
WITHDRAWN: HM47118A, a novel insulinotropic GPR119 agonist and potential oral antidiabetic agent
Song, T. H., Lee, S. D., Ha, Y. E., Choi, K. J., Lee, S. H., Kim, Y., Suh, K. H., & Chun, Y. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.011
Retracted
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.